{
  "claims": [
    {
      "id": 393530,
      "index": 1,
      "node_name": "claim 1",
      "node_value": "A tetrahydronaphthalen-2-ol derivative according to Formula 1&#10;&#10;&#10;&#10;&#10;wherein&#10;R1 is (C1-C4)alkyl, (C2-C4)alkenyl or (C2-C4)alkynyl, independently optionally substituted with one or more halogen, R1 having a cis-orientation in relation to both the exocyclic phenyl group at the 6-position and the benzyl group at the 8-position of the skeleton;&#10;R2-R13 are independently H, halogen, CN, OH, (C1-C4)alkyl, optionally substituted with one or more halogen, or (C1-C2)alkyloxy;&#10;&#10;or a prodrug or an isotopically-labelled derivative thereof.",
      "link_degree": 1,
      "references": [
        0
      ],
      "group": 1
    },
    {
      "id": 393533,
      "index": 2,
      "node_name": "claim 2",
      "node_value": "A tetrahydronaphthalen-2-ol derivative according to claim 1, wherein R1 is (C1-C4)alkyl, optionally substituted with one or more halogen.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 393536,
      "index": 3,
      "node_name": "claim 3",
      "node_value": "A tetrahydronaphthalen-2-ol derivative of Formula 1 according to claim 1&#10;&#10;&#10;&#10;&#10;wherein&#10;R1 is (C1-C4)alkyl, (C2-C4)alkenyl or (C2-C4)alkynyl, independently optionally substituted with one or more halogen, R1 having a cis-orientation in relation to both the exocyclic phenyl group at the 6-position and the benzyl group at the 8-position of the skeleton;&#10;R2-R6 are independently H, halogen, CN, OH, (C1-C4)alkyl, optionally substituted with one or more halogen or (C1-C2)alkoxy, with a maximum of two OH groups;&#10;R7-R13 are independently H, halogen, CN, (C1-C4)alkyl, optionally substituted with one or more halogen or (C1-C2)alkoxy;&#10;&#10;or a prodrug thereof.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 393539,
      "index": 4,
      "node_name": "claim 4",
      "node_value": "A tetrahydronaphthalen-2-ol derivative of Formula 1 according to claim 1&#10;&#10;&#10;&#10;&#10;wherein&#10;R1 is (C1-C4)alkyl, (C2-C4)alkenyl or (C2-C4)alkynyl, independently optionally substituted with one or more halogen, R1 having a cis-orientation in relation to both the exocyclic phenyl group at the 6-position and the benzyl group at the 8-position of the skeleton;&#10;R2-R13 are independently H, halogen, CN, OH, (C1-C4)alkyl, optionally substituted with one or more halogen or (C1-C2)alkoxy, with a maximum of five R2-R13 groups unequal to H.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 393542,
      "index": 5,
      "node_name": "claim 5",
      "node_value": "A tetrahydronaphthalen-2-ol derivative of Formula 1 according to claim 1&#10;&#10;&#10;&#10;&#10;wherein&#10;R1 is methyl, ethyl or propyl;&#10;R2 is H, chlorine, fluorine, CN, methoxy or methyl;&#10;R3-R7 and R10 are H or fluorine;&#10;R8, R9, R11 and R13 are H;&#10;R12 is H, fluorine or methyl.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 393545,
      "index": 6,
      "node_name": "claim 6",
      "node_value": "A tetrahydronaphthalen-2-ol derivative of Formula 2 according to claim 1&#10;&#10;&#10;&#10;&#10;wherein&#10;R1 is methyl, ethyl or propyl;&#10;R2 is H, chlorine, fluorine, CN, methoxy or methyl;&#10;R3-R7 and R10 are H or fluorine;&#10;R8, R9, R11 and R13 are H;&#10;R12 is H, fluorine or methyl.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 393548,
      "index": 7,
      "node_name": "claim 7",
      "node_value": "A tetrahydronaphthalen-2-ol derivative according to claim 6 selected from the group consisting of compounds according to Formula 2 wherein R1 is methyl, R2 is fluorine, and R3-R13 are H; R1 is ethyl, R2 is fluorine, and R3-R13 are H; R1 is methyl, R2 and R6 are fluorine, and R3-R5 and R7-R13 are H; R1 is methyl, R2 is CN, and R3-R13 are H; R1 is ethyl, R2 and R12 are fluorine, and R3-R11 and R13 are H; and R1 is ethyl, R4 is fluorine, and R2-R3 and R5-R13 are H.",
      "link_degree": 1,
      "references": [
        6
      ],
      "group": 1
    },
    {
      "id": 393551,
      "index": 8,
      "node_name": "claim 8",
      "node_value": "A tetrahydronaphthalen-2-ol derivative according to claim 7, wherein R1 is methyl, R2 is fluorine, and R3-R13 are H.",
      "link_degree": 1,
      "references": [
        7
      ],
      "group": 1
    },
    {
      "id": 393554,
      "index": 9,
      "node_name": "claim 9",
      "node_value": "A pharmaceutical composition comprising a tetrahydronaphthalen-2-ol derivative according to claim 1 and one or more pharmaceutically acceptable excipients.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 393557,
      "index": 10,
      "node_name": "claim 10",
      "node_value": "A method for the treatment of a mammal suffering from a disease or disorder selected from the group consisting of lower urinary tract symptoms, benign prostate hyperplasia, prostate cancer, hot flushes, anxiety, depression, breast cancer, medullary thyroid carcinoma, ovarian cancer, inflammatory bowel disease, arthritis, endometriosis and colon cancer, the method comprising administering a therapeutically effective amount of a tetrahydronaphthalen-2-ol derivative according to claim 1.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 393560,
      "index": 11,
      "node_name": "claim 11",
      "node_value": "The method according to claim 10, wherein the disorder or disease is selected from the group consisting of lower urinary tract symptoms, benign prostate hyperplasia, prostate cancer, breast cancer, medullary thyroid carcinoma, ovarian cancer, endometriosis and colon cancer.",
      "link_degree": 1,
      "references": [
        10
      ],
      "group": 1
    },
    {
      "id": 393563,
      "index": 12,
      "node_name": "claim 12",
      "node_value": "The method according to claim 11, wherein the disorder or disease is selected from the group consisting of lower urinary tract symptoms, benign prostate hyperplasia and prostate cancer.",
      "link_degree": 1,
      "references": [
        11
      ],
      "group": 1
    }
  ],
  "claim_links": [
    {
      "source": 393533,
      "target": 393530,
      "value": 1
    },
    {
      "source": 393536,
      "target": 393530,
      "value": 1
    },
    {
      "source": 393539,
      "target": 393530,
      "value": 1
    },
    {
      "source": 393542,
      "target": 393530,
      "value": 1
    },
    {
      "source": 393545,
      "target": 393530,
      "value": 1
    },
    {
      "source": 393548,
      "target": 393545,
      "value": 1
    },
    {
      "source": 393551,
      "target": 393548,
      "value": 1
    },
    {
      "source": 393554,
      "target": 393530,
      "value": 1
    },
    {
      "source": 393557,
      "target": 393530,
      "value": 1
    },
    {
      "source": 393560,
      "target": 393557,
      "value": 1
    },
    {
      "source": 393563,
      "target": 393560,
      "value": 1
    }
  ],
  "links": {
    "is_parentChem_of": [
      {
        "source": 393557,
        "target": 393560,
        "source_value": "endometriosis",
        "target_value": "endometriosis"
      }
    ]
  }
}